Clarivate Announces Full Redemption of Remaining $100 Million Senior Secured Notes Due 2026 and Provides Update on Capital Allocation Activities
Clarivate (NYSE: CLVT) announced that subsidiary Camelot Finance S.A. fully redeemed the remaining $100 million aggregate principal of its 4.50% senior secured notes due 2026 on Jan 30, 2026, paying 100% of principal plus accrued interest.
Rhea-AI Summary
Clarivate (NYSE: CLVT) announced that subsidiary Camelot Finance S.A. fully redeemed the remaining $100 million aggregate principal of its 4.50% senior secured notes due 2026 on Jan 30, 2026, paying 100% of principal plus accrued interest.
The redemption was funded with cash on hand and is part of Clarivate's capital allocation strategy, which also included repurchasing ~56 million ordinary shares for $225 million in 2025 (including ~21 million shares for $75 million in Q4 2025).
Positive
- Full redemption of $100 million 2026 secured notes completed on Jan 30, 2026
- Share repurchases of 56 million ordinary shares for $225 million in 2025
- Redemption funded with cash on hand, improving financial flexibility
Negative
- Repurchases of $225 million reduced cash reserves available for other uses
Key Figures
- Redeemed notes principal
- $100 million
- Remaining 4.50% senior secured notes due 2026, redeemed Jan 30, 2026
- Coupon rate
- 4.50%
- Senior secured notes due 2026 originally issued Oct 31, 2019
- Redemption price
- 100% of principal + interest
- Cash redemption of remaining 2026 notes on Jan 30, 2026
- Q4 2025 buybacks
- ≈21 million shares / $75 million
- Ordinary shares repurchased during Q4 2025
- 2025 full-year buybacks
- ≈56 million shares / $225 million
- Ordinary shares repurchased during full year 2025
- Shares outstanding
- 661,435,069 shares
- Outstanding as of Sep 30, 2025 per S-3ASR summary
- Registered resale shares
- 245,076,317 shares
- Ordinary shares registered for resale under Form S-3 shelf
- Market cap pre-news
- $1,785,874,686
- Based on price of $2.65 before this announcement
Historical Context
-
Announcement of upcoming Q4 and full-year 2025 earnings release and call.
-
Launch of Clarivate Nexus academic assistant integrating trusted resources into AI tools.
-
Publication of Top 100 Global Innovators 2026 highlighting leading invention activity.
-
MongoDB announcement of expanded AI capabilities and Voyage 4 model integrations.
-
Release of Drugs to Watch 2026 report naming eleven potential blockbuster therapies.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
senior secured notes financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
The 2026 Notes were redeemed on January 30, 2026 (the "Redemption Date") at a cash redemption price equal to
This redemption was funded with cash on hand and is consistent with Clarivate's ongoing efforts to simplify its capital structure, reduce debt, and enhance financial flexibility.
As part of its broader capital allocation strategy, Clarivate also announced that it repurchased approximately 21 million ordinary shares for
"The full redemption of our remaining 2026 Notes, combined with our share repurchase activity throughout 2025, reflects the continued execution of our disciplined capital allocation strategy," said Jonathan Collins, Executive Vice President and Chief Financial Officer. "We remain focused on strengthening our balance sheet, enhancing financial flexibility, and driving long‑term value creation for our shareholders."
Forward-Looking Statements
This release includes statements that express our opinions, expectations, beliefs, plans, objectives, assumptions, or projections regarding future events or future results and therefore are, or may be deemed to be, "forward-looking statements" within the meaning of the "safe harbor provisions" of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms "believes," "estimates," "anticipates," "expects," "seeks," "projects," "intends," "plans," "may," "will," or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts, and include statements regarding our intentions, beliefs, or current expectations concerning, among other things, anticipated cost savings, results of operations, financial condition, liquidity, prospects, growth, strategies, and the markets in which we operate. Such forward-looking statements are based on available current market material and management's expectations, beliefs, and forecasts concerning future events impacting us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks and uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in Item 1A. Risk Factors in our annual report on Form 10-K, along with our other filings with the
About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-announces-full-redemption-of-remaining-100-million-senior-secured-notes-due-2026-and-provides-update-on-capital-allocation-activities-302675789.html
SOURCE Clarivate Plc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.